Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06360055Recruiting
Open-label, single-arm trial of d-mannose, sponsored by Peking University Third Hospital. Primary endpoints: Plasma concentration of dabigatran at 24 hours and Serum concentrations of glycoomics such as D-mannose at 1.5 hours. Started Apr 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06360055.